Cellular Dynamics Q1 Revenues Improve 21 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Cellular Dynamics reported after the close of the market on Monday that revenues in its first quarter were up 21 percent year over year, driven by collaborations and partnerships.

The company said that for the three months ended March 31, it had $2.9 million in revenues, compared to $2.4 million in the first quarter of 2013. Product sales were down 17 percent to $1.5 million from $1.8 million, but collaborations, partnerships, and other revenues more than doubled to $1.5 million from $636,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.